Results 201 to 210 of about 772,376 (319)

The reversal potential of excitatory amino acid action on granule cells of the rat dentate gyrus.

, 1984
Vincenzo Crunelli, Susan Forda, John Kelly   +2 more
openalex   +2 more sources

Identification of Sodium Channel Isoforms That Mediate Action Potential Firing in Lamina I/II Spinal Cord Neurons [PDF]

, 2011
Michael E. Hildebrand, Janette Mezeyova, Paula L. Smith, Michael W. Salter, Elizabeth Tringham, Terrance P. Snutch   +5 more
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

The brain-eye connection: More than just action potentials. [PDF]

J Exp Med
Walsh J.
europepmc   +1 more source

174 FUNCTIONAL CORE MODULATION FOLLOWING TREATMENT OF MINIMAL HEPATIC ENCEPHALOPATHY WITH L-ORNITHINE L-ASPARTATE: A POTENTIAL NOVEL MECHANISM OF ACTION

, 2011
M Mcphail, Robert Leech, Vijay P.B. Grover, Julie Fitzpatrick, Novraj S. Dhanjal, Brian K. Saxby, Keith Wesnes, H.C. Thomas, RM Wise, Simon D. Taylor‐Robinson   +9 more
openalex   +1 more source

Comparison of antidromic and orthodromic action potentials of identified motor axons in the cat's brain stem. [PDF]

, 1983
P. Gogan, J. P. Guéritaud, Suzanne Tyč-Dumont   +2 more
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Calmodulin D133H Disrupts Ca_v1.2 and K_v7.1 Regulation to Prolong Cardiac Action Potentials in Long QT Syndrome. [PDF]

Cells
Gupta N, McCormick LF, Richards EMB, Wadmore K, Morris R, Morris VS, Kirilenko P, Fowler ED, Dart C, Helassa N.   +9 more
europepmc   +1 more source

Electrically evoked compound action potentials in cochlear implant users with preoperative residual hearing. [PDF]

Front Hum Neurosci, 2023
Liebscher T, Hornung J, Hoppe U.
europepmc   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source